Skip to main content

Stoke Therapeutics, Inc.

STOK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001623526

In the last 90 days, Stoke Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 197 institutions reported holding it in 13F filings for Q2 2026, worth $2.49B in total; no superinvestor holds it.

Q1 2023 vs. Q4 2022

How the institutions holding Stoke Therapeutics, Inc. changed between Q4 2022 and Q1 2023.

All holders in Q1 2023All holders in Q4 2022

13F holders of STOK: Q4 2022 compared with Q1 2023
MeasureQ4 2022Q1 2023Change
Holders10797−10
Shares40.3M44.5M+4.25M (+10.5%)
Value$371.8M$371.8M−$14.1K (0.0%)

New holders (6)

Institutions that held Stoke Therapeutics, Inc. at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to STOK in Q1 2023
InstitutionSharesValue% of portfolio
Simplify Asset Management Inc.122,796$1.02M0.18%
Man Group plc–$872.9K0.00%
Woodline Partners LP97,024$808.2K0.01%
Squarepoint Ops LLC17,851$148.7K0.00%
Susquehanna International Group, LLP15,522$129.3K0.00%
UBS Asset Management Americas Inc11,398$94.9K0.00%

Sold out (16)

Institutions that held Stoke Therapeutics, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.

Institutions that sold out of STOK in Q1 2023
InstitutionShares, Q4 2022Value, Q4 2022
Bank of Montreal427,888$3.96M
Norges Bank394,312$3.64M
Sphera Funds Management Ltd.188,640$1.74M
Acadian Asset Management LLC77,194$711.0K
Two Sigma Advisers, LP36,600$337.8K
Balyasny Asset Management LLC29,038$268.0K
Victory Capital Management Inc18,581$171.5K
Jump Financial, LLC15,552$143.5K
Rafferty Asset Management, LLC14,429$133.2K
Landscape Capital Management, L.L.C.13,936$128.6K
Simplex Trading, LLC10,658$98.0K
Credit Suisse AG9,859$91.0K
Quantbot Technologies LP3,291$30.4K
Point72 Middle East FZE1,721$15.9K
Aquatic Capital Management LLC100$1.00K
GWM Advisors LLC75$692